Bruker Corporation

DB:BKD Stock Report

Market Cap: €7.0b

Bruker Past Earnings Performance

Past criteria checks 0/6

Bruker's earnings have been declining at an average annual rate of -30.6%, while the Life Sciences industry saw earnings declining at 4.5% annually. Revenues have been growing at an average rate of 9.6% per year.

Key information

-30.59%

Earnings growth rate

-30.06%

EPS growth rate

Life Sciences Industry Growth26.83%
Revenue growth rate9.55%
Return on equity-2.65%
Net Margin-3.05%
Last Earnings Update30 Jun 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Bruker makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:BKD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 263,500-107968394
31 Mar 263,459-36960399
31 Dec 253,437-22944395
30 Sep 253,439-24945400
30 Jun 253,44380933400
31 Mar 253,44680923392
31 Dec 243,366113893377
30 Sep 243,241305853356
30 Jun 243,120352802329
31 Mar 243,001402763308
31 Dec 232,965427730295
30 Sep 232,818319687275
30 Jun 232,715319644260
31 Mar 232,621312625248
31 Dec 222,531297608236
30 Sep 222,506275598231
30 Jun 222,476274605226
31 Mar 222,458282577223
31 Dec 212,418277563221
30 Sep 212,362270544220
30 Jun 212,264238518216
31 Mar 212,118204485204
31 Dec 201,988158472198
30 Sep 201,960158470188
30 Jun 201,970165480185
31 Mar 202,035177503190
31 Dec 192,073197500188
30 Sep 192,026207491186
30 Jun 191,972189473182
31 Mar 191,925184459177
31 Dec 181,896180449173
30 Sep 181,87398443172
30 Jun 181,84292440171
31 Mar 181,81384432167
31 Dec 171,76679420162
30 Sep 171,706151407157
30 Jun 171,664161399154
31 Mar 171,621152396151
31 Dec 161,611154394148
30 Sep 161,619146393148
30 Jun 161,621111393144
31 Mar 161,646119390145
31 Dec 151,624102392146
30 Sep 151,65466408151

Quality Earnings: BKD is currently unprofitable.

Growing Profit Margin: BKD is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BKD is unprofitable, and losses have increased over the past 5 years at a rate of 30.6% per year.

Accelerating Growth: Unable to compare BKD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BKD is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (11.5%).

Return on Equity

High ROE: BKD has a negative Return on Equity (-2.65%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/13 13:54
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bruker Corporation is covered by 34 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luke SergottBarclays
Lu LiBofA Global Research
Michael RyskinBofA Global Research